高级检索
当前位置: 首页 > 详情页

A MULTICENTER RANDOMIZED STUDY IN RHEUMATOID ARTHRITIS TO COMPARE IGURATIMOD, METHOTREXATE, OR COMBINATION: 52 WEEK EFFICACY AND SAFETY RESULTS OF THE SMILE TRIAL

| 导出 | |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Renji Hospital of Shanghai Jiao Tong University School of Medicine, Department of Rheumatology, Shanghai, China [2]The First Affiliated Hospital of Anhui Medical University, Department of Rheumatology and Immunology, Hefei, China [3]The First Affiliated Hospital of USTC, Department of Rheumatology and Immunology, Hefei, China [4]Peking University People’s Hospital, Department of Rheumatology and Immunology, Beijing, China [5]Qilu Hospital of Shandong University, Department of Rheumatology, Jinan, China [6]Xiangya Hospital Central South University, Department of Rheumatology and Immunology, Changsha, China [7]China- Japan Union Hospital of JiLin University, Department of Rheumatology and Immunology, Changchun, China [8]Changhai Hospital of Shanghai, Department of Rheumatology and Immunology, Shanghai, China [9]First Affiliated Hospital, Nanjing Medical University, Department of Rheumatology and Immunology, Nanjing, China [10]The Second Affiliated Hospital Zhejiang University School of Medicine, Department of Rheumatology and Immunology, Hangzhou, China [11]ShangHai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine, Department of Rheumatology, Shanghai, China [12]Xijing Hospital, Fourth Military Medical University, Department of Clinical Immunology, Xi’an, China [13]First Affiliated Hospital, Bengbu Medical College, Department of Rheumatology and Immunology, Bengbu, China [14]The Second Affiliated Hospital, Harbin Medical University, Department of Rheumatology and Immunology, Harbin, China [15]First Affiliated Hospital of Kunming Medical University, Department of Rheumatology and Immunology, Kunming, China [16]The Second Affiliated Hospital of Guangzhou Medical University, Department of Rheumatology and Immunology, Guangzhou, China [17]Jining No.1 People’s Hospital, Department of Rheumatology and Immunology, Jining, China [18]The Second Xiangya Hospital of Central South University, Department of Rheumatology and Immunology, Changsha, China [19]The Third Xiangya Hospital of Central South University, Department of Nephropathy and Rheumatology, Changsha, China [20]Zhuzhou Central Hospital, Department of Rheumatology and Immunology, Zhuzhou, China [21]Fudan University Zhongshan Hospital, Department of Rheumatology and Immunology, Shanghai, China [22]The First Affiliated Hospital of Shantou University Medical College, Department of Rheumatology, Shantou, China [23]The First Affiliated Hospital of Soochow University, Department of Rheumatology, Suzhou, China [24]West China Hospital, Department of Rheumatology and Immunology, Chengdu, China [25]Tianjin Medical University General Hospital, Department of Rheumatology and Immunology, Tianjin, China [26]China-Japan Friendship Hospital, Department of Rheumatology and Immunology, Beijing, China [27]Tongji Hospital Tongji Medical College of HUST, Department of Rheumatology and Immunology, Wuhan, China [28]The First Hospital of China Medical University, Department of Rheumatology and Immunology, Shenyang, China
出处:
ISSN:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 医学
小类 | 1 区 风湿病学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 风湿病学
JCR分区:
出版当年[2021]版:
Q1 RHEUMATOLOGY
最新[2023]版:
Q1 RHEUMATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Renji Hospital of Shanghai Jiao Tong University School of Medicine, Department of Rheumatology, Shanghai, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)